Pharmaceutical

TerSera’s ZOLADEX LA gains Health Canada approval for breast cancer

TerSera has obtained Health Canada approval for ZOLADEX LA 10.8mg to manage oestrogen receptor-positive (ER+) early breast cancer.

May 9, 2024 - 00:00
TerSera’s ZOLADEX LA gains Health Canada approval for breast cancer
TerSera has obtained Health Canada approval for ZOLADEX LA 10.8mg to manage oestrogen receptor-positive (ER+) early breast cancer.
Read the original article

Tags:

Previous Article

BioVersys and GSK expand their partnership for TB treatment alpibectir

Next Article

Broken String Biosciences teams up with Francis Crick Institute for ALS research

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

CinDome Pharma secures $40m to advance gastroparesis treatment

CinDome Pharma secures $40m to advance gastroparesis tr...

May 19, 2024

STAT+: Patients want test results now, and radiologists need time to explain. Can they meet in the middle?

STAT+: Patients want test results now, and radiologists...

Dec 1, 2023

As England’s virus hospitalisations surge flu vaccines evolve

As England’s virus hospitalisations surge flu vaccines ...

Feb 2, 2024